ultrainnovative – Tackle rare and dynamic challenges
Ultragenyx is preparing for the potential commercialization of a rare disease Antisense oligonucleotide therapy for the treatment of Angelman Syndrome. We are seeking a highly analytical, collaborative MBA Intern to support global launch readiness with a specific focus on Phase 3 (Ph3) data–driven scenario planning. This role will help design and execute workstreams and trigger-based plans that activate when Ph3 data become available. For example, the intern may lead pressure-testing a comprehensive plan to update the forecast, value proposition, Target Product Profile (TPP), positioning, and developing and testing core messages under different data readout scenarios (e.g., positive primary endpoint, mixed/secondary strength, subgroup effects).
Work Model:Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed.
Responsibilities:- Build a scenario framework for anticipated Ph3 readouts (primary/secondary endpoint outcomes, safety profile ranges, subpopulation signals, sensitivity analyses).
- Work with the cross-functional team to design decision trees and activation triggers linked to each scenario, mapping implications for updating all global materials.
- Define insight needs (ad boards, message testing, ATUs, discrete choice/TPP trade-offs, analog analysis) triggered by each scenario.
- Recommend governance cadence (war room / stand-ups, escalation paths, decision logs) for the 0–90 days post-readout window.
- Current MBA student (rising 2nd year or equivalent) with a focus in Marketing, Strategy, Healthcare Management, or Finance.
- 2–3+ years pre-MBA experience in biopharma, life sciences consulting, healthcare investing/analytics, or related.
- Strong strategic thinking and structured problem solving; comfort with ambiguity and scenario-based planning.
- Excellent communication and stakeholder management skills
- Optional Experience in neurology, CNS, or rare/orphan diseases, or early/first launch environments.
U.S. Hourly Wage Range:
- $35.00-$45.00 per hour. The estimated hourly range reflects an anticipated range for this position. The actual hourly wage offered will depend on the candidate’s prior experience level.
#LI-AJ1 #LI-Remote
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at [email protected].
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Similar Jobs
What We Do
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
